Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
First Edition of World Conference on Early Detection of Cancer Set to Start in November in Hainan, China 2021-08-16 22:13
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors 2021-08-16 20:00
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19 2021-08-16 15:29
GeneQuantum announces a key leadership appointment 2021-08-16 10:00
InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer 2021-08-16 09:31
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India 2021-08-16 08:00
WuXi AppTec Reports Strong 2021 Interim Results 2021-08-12 17:52
NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality Technology to Enhance Diagnosis, Education and Patient Care 2021-08-12 15:00
ImmVira's MVR-T3011 IV Completed First Dosing for Intravenous Administration in a U.S. Phase I Clinical Trial 2021-08-11 10:45
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China 2021-08-10 23:39
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization from the U.S. Food and Drug Administration 2021-08-10 22:00
FibroBiologics Announces Inaugural Board of Directors 2021-08-06 22:01
ABL Bio Receives IND Approval for Phase 1 Clinical Trial of ABL501, an anti-LAG-3/PD-L1 Bispecific Antibody 2021-08-04 21:30
Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's 2021-08-04 20:39
Happiness Biotech Announced Financial Results for Fiscal Year Ended March 31, 2021 2021-08-02 20:00
Bionomics Announces Plans to Conduct U.S. Initial Public Offering 2021-08-02 18:00
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines 2021-08-02 15:25
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic 2021-08-02 11:11
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report 2021-07-30 21:05
I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease 2021-07-30 20:00
1 102 103 104 105 106 222